Put Options

8 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$5.8 - $6.95 $2,900 - $3,475
500 Added 500.0%
600 $4,000
Q2 2024

Aug 14, 2024

SELL
$6.34 - $8.81 $1,268 - $1,762
-200 Reduced 66.67%
100 $0
Q1 2024

May 15, 2024

SELL
$8.51 - $10.19 $23,828 - $28,532
-2,800 Reduced 90.32%
300 $2,000
Q4 2023

Feb 14, 2024

BUY
$8.59 - $10.89 $15,462 - $19,602
1,800 Added 138.46%
3,100 $32,000
Q3 2023

Nov 14, 2023

SELL
$9.58 - $11.25 $16,286 - $19,125
-1,700 Reduced 56.67%
1,300 $12,000
Q2 2023

Aug 14, 2023

SELL
$7.68 - $10.44 $115,200 - $156,600
-15,000 Reduced 83.33%
3,000 $28,000
Q1 2023

May 15, 2023

BUY
$6.9 - $10.77 $55,200 - $86,160
8,000 Added 80.0%
18,000 $139,000
Q4 2022

Feb 14, 2023

BUY
$6.96 - $9.27 $69,600 - $92,700
10,000 New
10,000 $86,000

Others Institutions Holding INFU

About InfuSystem Holdings, Inc


  • Ticker INFU
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 20,694,800
  • Market Cap $193M
  • Description
  • InfuSystem Holdings, Inc., through its subsidiaries, provides infusion pumps, and related products and services in the United States and Canada. The company operates in two segments, Integrated Therapy Services (ITS) and Durable Medical Equipment Services (DME Services). It supplies electronic ambulatory infusion pumps and associated disposable ...
More about INFU
Track Ken Griffin's Portfolio

Track Ken Griffin Portfolio

Follow Ken Griffin (Citadel Advisors LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.